Bristol-Myers Squibb Company
Compositions and methods of treating cancer

Abstract:

The disclosure is directed to methods of treating cancer in subjects with a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propana- mide, or a salt thereof.